NANOBIOTIX to Participate in Multiple Investor Conferences in November

GlobeNewswireOct 31 15:30

Nanobiotix Updates Voting Rights and Capital Shares

TipRanksOct 12 04:47

Express News | Nanobiotix SA : Jefferies Cuts Target Price to $10.6 From $11

BreakingsSep 23 13:16

Buy Rating Affirmed: Nanobiotix's Strong H1 2024 Performance and Promising Clinical Trials Fuel Optimism

TipRanksSep 19 17:26 · Ratings

Nanobiotix H1 Loss Narrows, Revenue Rises

MT NewswiresSep 19 05:18

NANOBIOTIX Expects Cash And Equivalents Of €66.3M As Of June-End, To Now Fund Operations Into Q4 2025, Compared To Q3 2025 In Prior Guidance

BenzingaSep 19 04:21